2 years ago

Verastem Receives Orphan Drug Designation from FDA for VS-5584 in Mesothelioma



BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), dedicated to discovering as well as developing drugs to treat cancer by the specific killing in read more...